Top of page

Corporate

Practice

Filters

Atea Pharmaceuticals $345 million IPO

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14…

Atea Pharmaceuticals $345 million IPO

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14…

Atea Pharmaceuticals $345 million IPO

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14…
Back to top